There\u2019s a silent revolution underway in the way we regulate Artificial Intelligence in medicine.<\/p>
For years, the conversation has been all about validation<\/strong>: collecting data, measuring performance, defining protocols, proving that the model works. But 2026 marks a turning point. AI models are no longer static systems. They\u2019re dynamic, adaptive, constantly learning from new data. From validation to governance.<\/strong><\/p> This is not a theoretical shift. It\u2019s already written into the upcoming regulatory frameworks \u2014 the EU AI Act<\/strong>, the EMA guidance<\/strong> on AI use, and the FDA\u2019s Predetermined Change Control Plan (PCCP)<\/strong>. Until recently, software was treated like a finished product \u2014 validated once, fixed parameters, released as a stable version. This raises new, practical questions regulators are already addressing:<\/p> The message from regulators is clear, and logical: The FDA has already formalized this through the PCCP<\/strong>, requiring companies not to \u201creact\u201d to change but to design for it<\/strong> – before approval, before commercialization. Europe is moving in the same direction. Under the AI Act<\/strong>, high-risk systems (including AI-enabled medical devices and clinical decision-support software) must be explainable, traceable, and continuously monitored. What does this mean for sponsors, startups, and medtech companies?<\/strong><\/p> It means that validating an algorithm is just the beginning. That requires:<\/p>
The logic was linear: if it works, it can be certified.<\/p>
It will no longer be enough to show that an algorithm works \u2014 we\u2019ll need to show that it will keep<\/strong> working over time, in real-world contexts, across diverse patients, data, and conditions.<\/p>
Which means the regulatory question is shifting: from \u201cIs the model valid now?\u201d<\/em> to \u201cCan we govern its evolution?\u201d<\/em><\/p>
All are converging on one message: compliance is no longer a one-off event, but a continuous process that must follow the algorithm through its entire lifecycle.<\/strong><\/p>
That no longer applies to adaptive, self-updating machine learning models. These can improve \u2014 but they can also drift. And what you can\u2019t govern, you can\u2019t control.<\/p>
It\u2019s not about how innovative<\/em> your AI is, but how responsibly you can govern it over time<\/em>.<\/p>
That means defining in advance which<\/em> parts of the model may evolve, how<\/em> they will be monitored, and how<\/em> safety will be preserved through each iteration.
Change is no longer a risk; it\u2019s part of the design.<\/p>
The EMA<\/strong> goes even further: AI must not only work<\/em>; it must be understandable, controllable, and justifiable.<\/em><\/p>
Governing it<\/strong> is the real responsibility \u2014 and the true competitive edge.<\/p>